ClinicalTrials.govpublic full text
Frontline Treatment of Follicular Lymphoma With AtezolizUmab and Obinutuzumab With and Without RadiOtherapy
follicular lymphoma, treatment naive advanced disease, anti pd-l1 antibody, anti-cd20 antibody, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 807181
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.